Syndax Pharmaceuticals Inc — Form D

Syndax Pharmaceuticals Inc of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-05. The offering totals $7.0M, of which $6.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Joanna Horobin, M.D.DirectorWaltham, MA
Kim Kamdar, PhDDirectorWaltham, MA
Rosina Maar Pavia, M.D.DirectorWaltham, MA
Steven St. Peter, M.D.DirectorWaltham, MA
Robert Goodenow, PhDExecutive OfficerWaltham, MA
Joanna Horobin, M.D.Executive OfficerWaltham, MA
Ivor RoystonDirectorLa Jolla, CA
Arlene MorrisDirectorHolytown, Motherwell, X0
Arlene MorrisExecutive OfficerHolytown, Motherwell, X0
Dennis PodlesakDirectorSAN DIEGO, CA
Kim Kamdar, Ph.D.DirectorSan Diego, CA
Fabrice Egros, Ph.D.DirectorWaltham, MA
Michael W MetzgerExecutive OfficerWaltham, MA
Kim Kamdar, Ph.DDirectorWaltham, MA
Luke Evnin, Ph.D.DirectorWaltham, MA
Ivor Royston, M.D.DirectorWaltham, MA
George W Sledge, Jr., M.D.DirectorWaltham, MA
John PalliesExecutive OfficerWaltham, MA
Richard P SheaDirectorWaltham, MA
Henry W ChenDirectorWaltham, MA
Briggs W Morrison, M.D.DirectorWaltham, MA
Briggs W Morrison, M.D.Executive OfficerWaltham, MA
George W Sledge, Jr. M.D.DirectorWaltham, MA
Fabrice EgrosDirectorWaltham, MA
Robert Goodenow, Ph.D.Executive OfficerWaltham, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2015-08-28D$61.3M$61.3M
2015-06-15D$45.2M$24.0M
2014-09-19D$5.0M$4.9M
2014-02-13D$1.3M$1.3M
2014-02-13D$1.7M$1.7M
2013-11-14D$50K$50K
2013-08-30D$48.4M$31.3M
2010-02-03D$16.0M$9.0M

More